Prins MLM, Prins C, de Vries JJC, Visser LG, Roukens AHE.
Virus Res. 2023 Sep;334:199175. doi: 10.1016/j.virusres.2023.199175. Epub 2023 Jul 21.PMID: 37473964
Vos PJ, Kuijt N, Kaya M, Rol S, van der Maaden K.
Eur J Pharm Sci. 2020 Jul 1;150:105331. doi: 10.1016/j.ejps.2020.105331. Epub 2020 May 26.
Schepens B, Vos PJ, Saelens X, van der Maaden K.
Eur J Pharm Biopharm. 2019 Mar;136:259-266. doi: 10.1016/j.ejpb.2019.02.002. Epub 2019 Feb 5.PMID: 30731115
de Groot AM, Platteel ACM, Kuijt N, van Kooten PJS, Vos PJ, Sijts AJAM, van der Maaden K.
Front Immunol. 2017 Dec 13;8:1789. doi: 10.3389/fimmu.2017.01789. eCollection 2017.PMID: 29375544
Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays.
van der Maaden K, Luttge R, Vos PJ, Bouwstra J, Kersten G, Ploemen I.
Drug Deliv Transl Res. 2015 Aug;5(4):397-406. doi: 10.1007/s13346-015-0238-y.PMID: 26044672
Controlled release of a model vaccine by nanoporous ceramic microneedle arrays.
Boks MA, Unger WW, Engels S, Ambrosini M, Kooyk Yv, Luttge R.
Int J Pharm. 2015 Aug 1;491(1-2):375-83. doi: 10.1016/j.ijpharm.2015.06.025. Epub 2015 Jun 23.PMID: 26116016
Ex vivo evaluation of a microneedle array device for transdermal application.
Indermun S, Choonara YE, Kumar P, du Toit LC, Modi G, van Vuuren S, Luttge R, Pillay V.
Int J Pharm. 2015 Dec 30;496(2):351-9. doi: 10.1016/j.ijpharm.2015.09.070. Epub 2015 Oct 21.PMID: 26453791
Hartmann XH, van der Linde P, Homburg EF, van Breemen LC, de Jong AM, Luttge R.
Pharmaceutics. 2015 Nov 18;7(4):503-22. doi: 10.3390/pharmaceutics7040503.
